Physician profile
Robert Delbene
NPI 1023004447
$3,239.63
in general payments reported to CMS, 2019-2025
23 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $694 · 2021: $337 · 2022: $653 · 2023: $712 · 2024: $238 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $645.90 | 2020 | |
| Smith+Nephew, INC. | $450.79 | 2019-2025 | Grafix Pl, Stravix Pl, Grafix Xc |
| Amgen INC. | $293.20 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $266.37 | 2022-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $206.24 | 2021 | |
| Averitas Pharma INC. | $181.35 | 2023-2024 | Qutenza |
| Linvatec Corporation | $163.71 | 2025 | Rts |
| Acera Surgical, INC. | $160.89 | 2022-2023 | Restrata Wound Matrix |
| Next Science LLC | $151.22 | 2023 | Blastx, Xperience, Surgx |
| Nevro Corp. | $111.95 | 2022 | |
| Paratek Pharmaceuticals, INC. | $109.42 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $108.15 | 2021-2025 | Affinity |
| Amniox Medical, INC. | $100.00 | 2019 | |
| Convatec INC. | $62.48 | 2021-2023 | |
| Wright Medical Technology, INC. | $48.56 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $33.54 | 2022 | |
| Grt US Holding, INC. | $31.01 | 2022 | |
| Hartmann USA, INC. | $29.74 | 2021 | |
| Depuy Synthes Sales INC. | $20.02 | 2019 | |
| Stryker Corporation | $17.98 | 2024 | Prostep, Ortholoc 3di |
| Paragon 28, INC. | $16.91 | 2019 | |
| Medtronic, INC. | $15.92 | 2024 | Intellis Adaptivestim |
| Mimedx Group, INC. | $14.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Delbene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.